Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts

Author:

Takahashi Masamichi12ORCID,Miki Shunichiro12,Fujimoto Kenji2,Fukuoka Kohei2,Matsushita Yuko12,Maida Yoshiko3,Yasukawa Mami3,Hayashi Mitsuhiro4,Shinkyo Raku5,Kikuchi Kiyomi5,Mukasa Akitake6,Nishikawa Ryo7,Tamura Kenji8ORCID,Narita Yoshitaka1,Hamada Akinobu4,Masutomi Kenkichi3,Ichimura Koichi2ORCID

Affiliation:

1. Department of Neurosurgery and Neuro‐Oncology National Cancer Center Hospital Tokyo Japan

2. Division of Brain Tumor Translational Research National Cancer Center Research Institute Tokyo Japan

3. Division of Cancer Stem Cell National Cancer Center Research Institute Tokyo Japan

4. Division of Molecular Pharmacology National Cancer Center Research Institute Tokyo Japan

5. Tsukuba Research Laboratory Eisai Tsukuba Japan

6. Department of Neurosurgery The University of Tokyo Tokyo Japan

7. Department of Neuro‐Oncology/Neurosurgery Saitama Medical University International Medical Center Hidaka Japan

8. Department of Breast and Medical Oncology National Cancer Center Hospital Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3